Letter to the editor: Using intratumoral steatosis to predict the efficacy of combination therapy in nonviral hepatocellular carcinoma

Affiliations

Comment

Shi-Tao Jiang et al. Hepatology. 2022 Dec.

. 2022 Dec;76(6):E135-E136.

doi: 10.1002/hep.32628. Epub 2022 Jul 4.

¹ Department of Liver SurgeryPeking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical CollegeBeijingChina.

No abstract available

Comment on

Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma.
Murai H, Kodama T, Maesaka K, Tange S, Motooka D, Suzuki Y, Shigematsu Y, Inamura K, Mise Y, Saiura A, Ono Y, Takahashi Y, Kawasaki Y, Iino S, Kobayashi S, Idogawa M, Tokino T, Hashidate-Yoshida T, Shindou H, Miyazaki M, Imai Y, Tanaka S, Mita E, Ohkawa K, Hikita H, Sakamori R, Tatsumi T, Eguchi H, Morii E, Takehara T. Murai H, et al. Hepatology. 2023 Jan 1;77(1):77-91. doi: 10.1002/hep.32573. Epub 2022 Jun 17. Hepatology. 2023. PMID: 35567547 Free PMC article.

1. Murai H, Kodama T, Maesaka K, Tange S, Motooka D, Suzuki Y, et al. Multiomics identifies the link between intratumor steatosis and the exhausted tumor immune microenvironment in hepatocellular carcinoma. Hepatology. 2022. https://doi.org/10.1002/hep.32573 - DOI
1. Zhang Q, Lou Y, Yang J, Wang J, Feng J, Zhao Y, et al. Integrated multiomic analysis reveals comprehensive tumour heterogeneity and novel immunophenotypic classification in hepatocellular carcinomas. Gut. 2019;68:2019–31.
1. Hermida M, Preel A, Assenat E, Piron L, Cassinotto C, Ursic‐Bedoya J, et al. Small steatotic HCC: a radiological variant associated with improved outcome after ablation. Hepatol Commun. 2021;5:689–700.